Document 0619
 DOCN  M9480619
 TI    Low and stable prevalence of HIV among drug injectors in Glasgow.
 DT    9410
 AU    Taylor A; Frischer M; Green ST; Goldberg D; McKeganey N; Gruer L;
       Communicable Diseases and Environmental Health (Scotland) Unit,; Ruchill
       Hospital, UK.
 SO    Int J STD AIDS. 1994 Mar-Apr;5(2):105-7. Unique Identifier : AIDSLINE
       MED/94305003
 AB    The first HIV-positive diagnosis among injecting drug users (IDU) in
       Glasgow was made in 1985. By the end of 1987 prevalence among IDU
       receiving voluntary attributable tests was 4.8%. Since 1990, an annual
       cross-sectional survey of HIV prevalence and risk behaviours among 500
       current Glasgow IDU has provided a more representative sample.
       Anonymously-tested saliva samples obtained from respondents revealed
       prevalence rates of 1.8%, 1.2% and 1.0% in 1990, 1991 and 1992
       respectively. Since 1987 a wide range of measures aimed at reducing
       HIV-related risk behaviour among IDU has been introduced and maintained
       in Glasgow. Against this background, there is evidence that IDU in the
       city have reduced their risk behaviours. The findings reported here
       suggest that implementing harm-reduction measures when prevalence is low
       may inhibit the rapid dissemination of HIV.
 DE    Adult  AIDS Serodiagnosis  Cross-Sectional Studies  Health Behavior
       Human  HIV Infections/DIAGNOSIS/*EPIDEMIOLOGY/ETIOLOGY/PREVENTION &
       CONTROL/TRANSMISSION  HIV Seroprevalence/*TRENDS  *HIV-1  *Population
       Surveillance  Risk Factors  Risk-Taking  Sampling Studies
       Scotland/EPIDEMIOLOGY  Substance Abuse,
       Intravenous/*COMPLICATIONS/EPIDEMIOLOGY  Support, Non-U.S. Gov't  Urban
       Population  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).